Ani Pharmaceuticals Inc (ANIP) SEC Filings — 2024

Filings

• ANI Pharmaceuticals Files 8-K on Financials — 8-K · Nov 20, 2024
• Ani Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• ANI Pharmaceuticals Files Q3 2024 Report — 10-Q · Nov 8, 2024
• ANI Pharma Acquires Amneal Generic Drug Assets — 8-K · Sep 20, 2024
• ANI Pharmaceuticals Files 8-K — 8-K · Sep 16, 2024
• ANI Pharmaceuticals Reports Material Agreement Changes — 8-K · Aug 13, 2024
• ANI Pharmaceuticals Acquires Alaven Pharmaceuticals — 8-K · Aug 8, 2024
• ANI Pharmaceuticals Files 8-K — 8-K · Aug 7, 2024
• ANI Pharmaceuticals Files 8-K on Financials — 8-K · Aug 6, 2024
• ANI Pharma Acquires Atorvastatin Rights — 8-K · Jun 24, 2024
• ANI Pharma Acquires Opana ER Rights for $8M — 8-K · Jun 5, 2024
• ANI Pharma to Acquire Amneal's US Rx Business for $230M — 8-K · May 23, 2024
• ANI Pharmaceuticals Files 8-K on Financials — 8-K · May 14, 2024
• ANI Pharmaceuticals Reports Q1 2024 Results — 10-Q · May 10, 2024
• ANI Pharmaceuticals Files 8-K on Financials — 8-K · Apr 17, 2024
• ANI Pharmaceuticals Inc. Files Definitive Proxy Statement — DEF 14A · Apr 5, 2024
• Meridian Venture Partners Boosts ANI Pharma Stake — SC 13D/A · Mar 14, 2024
• ANI Pharmaceuticals Files 8-K on Financials — 8-K · Mar 12, 2024
• ANI Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
• ANI Pharma Enters Material Definitive Agreement — 8-K · Feb 23, 2024
• Vanguard Discloses 9.1% Stake in ANI Pharmaceuticals — SC 13G · Feb 13, 2024
• Rubric Capital Exits ANI Pharma Stake as of Dec 31, 2023 — SC 13G · Feb 12, 2024
• ANI Pharma Files 8-K on Financial Results & Reg FD Disclosure — 8-K · Feb 8, 2024
• BlackRock Updates ANI Pharma Stake as of Dec 31, 2023 — SC 13G/A · Jan 23, 2024
• Esjay LLC Amends ANI Pharma Stake, Signals Ownership Change — SC 13D/A · Jan 17, 2024
• ANI Pharma Files 8-K on Operations & Financial Condition — 8-K · Jan 8, 2024